ISPOR 2026
Sunday, May 17 - Wednesday, May 20
-
ECONOMIC EVALUATION AND BUDGET IMPACT ANALYSIS OF MICROWAVE ABLATION VS. RADIOFREQUENCY ABLATION AND SURGICAL RESECTION FOR EARLY-STAGE HEPATOCELLULAR CARCINOMA IN THE MEXICAN PUBLIC HEALTH SYSTEM
Mar 18, 2026, 21:38 PM -
A MODELING STUDY INVESTIGATING THE POTENTIAL OF MULTI-CANCER EARLY DETECTION SCREENING IN REDUCING CANCER INCIDENCE AND MORTALITY IN HIGH-RISK GROUPS
Mar 18, 2026, 21:38 PM -
COMPARATIVE EFFECTIVENESS OF PHARMACOLOGICAL TREATMENTS FOR STABLE CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN THE CHINESE POPULATION: A BAYESIAN NETWORK META ANALYSIS
Mar 18, 2026, 21:38 PM -
A MULTI-INDICATION HEALTH TECHNOLOGY ASSESSMENT FRAMEWORK FOR ONCOLOGICAL DRUGS IN THE BRAZILIAN PUBLIC HEALTH SYSTEM (SUS)
Mar 18, 2026, 21:38 PM -
INSIGHTS INTO RANGE OF MOTION (ROM) AND PHYSICAL FUNCTION (PF) CHANGES EXPERIENCED BY PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR (TGCT) IN THE MANEUVER PHASE 3 TRIAL: RESULTS FROM EXIT INTERVIEWS
Mar 18, 2026, 21:38 PM -
UNIT-CONSISTENT TRANSLATION OF TREATMENT EFFECTS INTO NUMBER NEEDED TO TREAT AND COST PER EVENT AVOIDED IN HEALTH ECONOMIC EVALUATIONS
Mar 18, 2026, 21:38 PM -
ESTIMATING PRICE ELASTICITIES OF ALCOHOL DEMAND IN CHINA (2010-2024)
Mar 18, 2026, 21:38 PM -
PREDICTORS OF GLP-1 RECEPTOR AGONIST USE AMONG U.S. ADULTS WITH COMORBID DEPRESSION AND TYPE 2 DIABETES MELLITUS
Mar 18, 2026, 21:38 PM -
THE IMPACT OF SIMPLIFIED DOSING TERMINOLOGY ON TREATMENT EXPOSURE AND BUSGET IMPACT ESTIMATES
Mar 18, 2026, 21:38 PM -
THE IMPACT OF PERIOPERATIVE IMMUNE CHECKPOINT INHIBITORS ON THE ECONOMIC BURDEN OF BLADDER CANCER IN CANADA
Mar 18, 2026, 21:38 PM -
DATA-DRIVEN BASELINE MATCHING: ENHANCING INDIRECT COMPARISONS WITH A MACHINE LEARNING-INFORMED FRAMEWORK FOR SELECTING HOMOGENEOUS TRIAL SETS
Mar 18, 2026, 21:38 PM -
MODELING RARE EVENTS IN HEALTH INTERVENTION: AN APPLICATION FROM THE DEPARTMENT OF WAR DATASET
Mar 18, 2026, 21:38 PM -
ADVANCING CLINICAL DEVELOPMENT AND EVIDENCE GENERATION THROUGH CAUSAL AI: A TARGETED REVIEW OF APPLICATIONS AND IMPLICATIONS FOR REGULATORY-GRADE EVIDENCE
Mar 18, 2026, 21:38 PM -
A DESCRIPTIVE COMPARISON OF U.S. MEDICARE IRA NEGOTIATED PRICES AND AVERAGE MFN BENCHMARKS FOR PART D DRUGS
Mar 18, 2026, 21:38 PM -
INFLAMMATORY BIOMARKERS AND RHEUMATOID ARTHRITIS: EVIDENCE FROM A US POPULATION-BASED NHANES STUDY
Mar 18, 2026, 21:38 PM -
GENERATIVE AI SECURES SYNTHETIC DATASETS OF NSCLC TRIAL COHORTS FOR RWD ANALYSIS: A PRIVACY-PRESERVING CASE STUDY
Mar 18, 2026, 21:38 PM -
QUANTIFYING THE LIFETIME HEALTH AND SOCIETAL BENEFITS OF TIMELY DIAGNOSIS AND ACCESS TO APPROVED TREATMENTS IN ANTI-ACETYLCHOLINE RECEPTOR ANTIBODY-POSITIVE (ACHR-AB+) GENERALIZED MYASTHENIA GRAVIS (GMG) IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
HOSPITALIZATION BURDEN IN PULMONARY ARTERIAL HYPERTENSION: EVIDENCE FROM SYSTEMATIC REVIEWS OF RCTS AND RWS
Mar 18, 2026, 21:38 PM -
COMPARISON OF HEALTHCARE COSTS BETWEEN RECONSTRUCTION PROCEDURE AND DIRECT AMPUTATION OF LOWER EXTREMITIES AMONG PATIENTS WITH DIABETIC NEUROPATHIC ARTHROPATHY
Mar 18, 2026, 21:38 PM -
POPULATION PHARMACOKINETIC MODELING OF A NOVEL ONCE-DAILY LITHIUM CARBONATE EXTENDED RELEASE (XR) BI-LAYER MATRIX FORMULATION TO SUPPORT FORMULATION SWITCHING AND PEDIATRIC DOSING
Mar 18, 2026, 21:38 PM